Pflanzliches Arzneimittel zur Behandlung von Hämorrhoidalen Erkrankungen

EP4785947 5. August 2026

Anmelder: Terra Lab International D.O.O. 🇭🇷

Details

Veröffentlichungs-Nr.
EP4785947
Anmeldetag
31. Januar 2025
Veröffentlichung
5. August 2026
Rechtsraum
EP
Offizieller Volltext

Abstract

The present disclosure is directed to three aspects, a pharmaceutical composition for use in treating hemorrhoidal disease and/ or the associated symptoms of hemorrhoidal disease, a method of producing said composition and a capsule comprising said composition. The pharmaceutical composition contains seven different herbal extracts of plant material of cichorium intybus, vitis vinifera, berberis aristate, hamamelis virginiana, azadirachta indica, aesculus hippocastanum and mesua ferrea that surprisingly alleviates symptoms of hemorrhoids and/or hemorrhoidal disease, even in cases where symptoms persist despite prior treatment with conventional local or oral medicinal therapies.

Anmelder

Firma
Terra Lab International D.O.O.
Land
🇭🇷 Kroatien

Vertreten von

Noch Fragen?

Wir helfen Ihnen gerne weiter. Schreiben Sie uns einfach.

Kontakt aufnehmen